Of note, we commenced our first mRNA contract for a customer at our Flanders2 GMP manufacturing facility, further strengthened our CleanCap® IVT capping technology patent estate with the issuance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback